DeutschNewstral
Paul Sax
COVID antiviral Paxlovid to see price increase following 400% vaccine hikeArs Technica
More young, healthy people should be getting Paxlovidvox.com
New Covid Boosters Expected This Fall: Why Some Doctors Suggest Holding Off On Getting Your Next Booster Until ThenForbes
Don’t get your next COVID booster quite yetThe New York Times- NHave the odds of getting long COVID changed?newsnationnow.com
No One Wants Your ColdThe Atlantic
Elon Musk declares his pronouns are ‘Prosecute/Fauci’ — and science claps backMerced Sun-Star- COVID Science Is Moving BackwardsThe Atlantic
Pfizer says its COVID pill doesn’t work for healthier patientsLA Times
Monkeypox testing shows the U.S. learned little from the covid-19 pandemic - Thu, 16 Jun 2022 PSTsyndication.washingtonpost.com- Nuevo misterio del COVID-19: algunos vuelven a contraer el coronavirus incluso después de tomar PaxlovidLA Times
- Why the FDA rejected fluvoxamine as a Covid-19 drugvox.com
New COVID-19 mystery: Some are getting coronavirus again even after taking Paxlovidpressherald.com
New COVID-19 mystery: Some are getting coronavirus again even after taking antiviralbangordailynews.com- They got sick, got treated, got COVID-19 again: Another rare virus puzzlepressherald.com
Covid-19 cases that return after antiviral treatment puzzle doctorsCNN
Another rare virus puzzle: They got sick, got treated, got covid againAlaska Dispatch News- Johnson & Johnson recipients can get third COVID shot in San FranciscoLA Times
- MWill this COVID-19 wave lead to herd immunity? Are you less likely to get sick again if you had omicron? Why this 'milder' variant is a double-edged sword7 min readmarketwatch.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.